preview

Who Is Martin Shkreli: Hero Or Villain?

Satisfactory Essays
Open Document

Martin Shkreli was the chief executive officer of Turing Pharmaceuticals and raised the price of pyrimethamine(or Daraprim) from $13.50 to $750 per pill. Daraprim is an antiparasicitic, and helps treat AIDS, malaria and toxoplasmosis. Shkreli had ‘Smugness, arrogance, and unapologetic greed’ which made him ‘a compelling villain.’ Shkreli had gained his position as CEO of Turing Pharmaceuticals by giving it to himself. Shkreli founded the company in February 2015, with three drugs that were still in development. Shkreli was the CEO of Retrophin before he became the CEO of Turing. This did not mean very much, however, as he was the one who founded it in 2011. Shkreli was not as corrupted by his power as he was just corrupted in general. Power

Get Access